Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles

Nanomedicine

Volumn 10, Issue 11, 2015, Pages 1775-1784

  Sengupta, Aritra ^a   Mezencev, Roman ^b   McDonald, John F ^b   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

EGFR; intracellular delivery; nanosecond laser; photoacoustics; siRNA

Indexed keywords

CARBON NANOPARTICLE; MESSENGER RNA; SMALL INTERFERING RNA; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; NANOPARTICLE; SOOT;

ARTICLE; CONTROLLED STUDY; EGFR GENE; GENE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; LASER; OVARIAN CANCER CELL LINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; FEMALE; GENETICS; OVARIAN NEOPLASMS; PATHOLOGY; RADIATION RESPONSE; SOOT; TUMOR CELL LINE;

CELL LINE, TUMOR; FEMALE; HUMANS; LASERS; NANOPARTICLES; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SOOT;

EID: 84931863378     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.27     Document Type: Article

References (48)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 391(6669), 806-811 (1998).
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836), 494-498 (2001).
3. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8(2), 129-138 (2009).
4. Frank-Kamenetsky M, Grefhorst A, Anderson NN et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl Acad. Sci. USA 105(33), 11915-11920 (2008).
5. Sato Y, Murase K, Kato J et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26(4), 431-442 (2008).
6. Song E, Lee SK, Wang J et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9(3), 347-351 (2003).
7. Morrissey DV, Lockridge JA, Shaw L et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23(8), 1002-1007 (2005).
8. Niu XY, Peng ZL, Duan WQ, Wang H, Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int. J. Gynecol. Cancer 16(2), 743-751 (2006).
9. Takeshita F, Minakuchi Y, Nagahara S et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl Acad. Sci. USA 102(34), 12177-12182 (2005).
10. Tabernero J, Shapiro GI, Lorusso PM et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 3(4), 406-417 (2013).
11. Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharmaceut. 6(3), 659-668 (2009).
12. Shegokar R, Al Shaal L, Mishra PR. SiRNA delivery: challenges and role of carrier systems. Pharmazie 66(5), 313-318 (2011).
13. Tomar RS, Matta H, Chaudhary PM. Use of adenoassociated viral vector for delivery of small interfering RNA. Oncogene 22(36), 5712-5715 (2003).
14. Devroe E, Silver PA. Retrovirus-delivered siRNA. BMC Biotechnol. 2, 15 (2002).
15. Hughes J, Yadava P, Mesaros R. Liposomal siRNA delivery. Methods Mol. Biol. 605, 445-459 (2010).
16. Podesta JE, Kostarelos K. Chapter 17-engineering cationic liposome siRNA complexes for in vitro and in vivo delivery. Methods Enzymol. 464, 343-354 (2009).
17. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312(5776), 1027-1030 (2006).
18. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA. Gene regulation with polyvalent siRNAnanoparticle conjugates. J. Am. Chem. Soc. 131(6), 2072-2073 (2009).
19. Davis ME, Zuckerman JE, Choi CH et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291), 1067-1070 (2010).
20. Lewis DL, Wolff JA. Systemic siRNA delivery via hydrodynamic intravascular injection. Adv. Drug Deliv. Rev. 59(2-3), 115-123 (2007).
21. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4(5), 346-358 (2003).
22. Howard DB, Powers K, Wang Y, Harvey BK. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372(1), 24-34 (2008).
23. DE Bruin KG, Fella C, Ogris M, Wagner E, Ruthardt N, Brauchle C. Dynamics of photoinduced endosomal release of polyplexes. J. Control. Release 130(2), 175-182 (2008).
24. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem. Rev. 109(2), 259-302 (2009).
25. Oishi M, Kataoka K, Nagasaki Y. pH-responsive threelayered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosomedisruptive nonviral gene vector. Bioconjug. Chem. 17(3), 677-688 (2006).
26. Rodriguez-Devora JI, Ambure S, Shi ZD, Yuan Y, Sun W, Xui T. Physically facilitating drug-delivery systems. Ther. Deliv. 3(1), 125-139 (2012).
27. Park HK, Kim D, Grigoropoulos CP, Tam AC. Pressure generation and measurement in the rapid vaporization of water on a pulsed?laser?heated surface. J. Appl. Phys. 80(7), 4072-4081 (1996).
28. Kitz M, Preisser S, Wetterwald A, Jaeger M, Thalmann GN, Frenz M. Vapor bubble generation around gold nanoparticles and its application to damaging of cells. Biomed. Opt. Express. 2(2), 291-304 (2011).
29. Chen H, Diebold G. Chemical generation of acoustic waves: a giant photoacoustic effect. Science 270(5238), 963-966 (1995).
30. Chakravarty P, Qian W, El-Sayed MA, Prausnitz MR. Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat. Nanotechnol. 5(8), 607-611 (2010).
31. Sengupta A, Kelly SC, Dwivedi N, Thadhani N, Prausnitz MR. Efficient intracellular delivery of molecules with high cell viability using nanosecond-pulsed laser-activated carbon nanoparticles. ACS Nano 8(3), 2889-2899 (2014).
32. Huang X, Pallaoro A, Braun GB et al. Modular plasmonic nanocarriers for efficient and targeted delivery of cancertherapeutic siRNA. Nano Lett. 14(4), 2046-2051 (2014).
33. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 62(1), 10-29 (2012).
34. Institute Nc. http://seer.cancer.gov/statfacts/html/ovary.html
35. Ozols RF. Treatment goals in ovarian cancer. Int. J. Gynecol. Cancer 15(Suppl. 1), 3-11 (2005).
36. Dickerson EB, Blackburn WH, Smith MH, Kapa LB, Lyon LA, McDonald JF. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer 10, 10 (2010).
37. Weissleder R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19(4), 316-317 (2001).
38. Stolik S, Delgado Ja, Pérez A, Anasagasti L. Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. J. Photochem. Photobiol. B 57(2-3), 90-93 (2000).
39. Han D, Meng Z, Wu D, Zhang C, Zhu H. Thermal properties of carbon black aqueous nanofluids for solar absorption. Nanoscale Res. Lett. 6, 457 (2011).
40. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63(3), 136-151 (2011).
41. Roduner E. Size matters: why nanomaterials are different. Chem. Soc. Rev. 35(7), 583-592 (2006).
42. Lubbers J, Graaff R. A simple and accurate formula for the sound velocity in water. Ultrasound Med. Biol. 24(7), 1065-1068 (1998).
43. Armstrong JK, Wenby RB, Meiselman HJ, Fisher TC. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J. 87(6), 4259-4270 (2004).
44. Liu H, Li Y, Mozhi A et al. siRNA-phospholipid conjugates for gene and drug delivery in cancer treatment. Biomaterials 35(24), 6519-6533 (2014).
45. Hallow DM, Mahajan AD, Mccutchen TE, Prausnitz MR. Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med. Biol. 32(7), 1111-1122 (2006).
46. Canatella PJ, Karr JF, Petros JA, Prausnitz MR. Quantitative study of electroporation-mediated molecular uptake and cell viability. Biophys. J. 80(2), 755-764 (2001).
47. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability. J. Acoust. Soc. Am. 110(1), 588-596 (2001).
48. Dalby B, Cates S, Harris A et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33(2), 95-103 (2004).